Saturday, June 27, 2026

#Eli Lilly

6 articles

Eli Lilly Tops $20B in 2026 Acquisitions, Betting AI Compresses Drug Development Timelines

Sector Consolidation

Eli Lilly Tops $20B in 2026 Acquisitions, Betting AI Compresses Drug Development Timelines

Salvado•May 31, 2026

NVIDIA BioNeMo Wins Lilly, Thermo Fisher as AI Drug Discovery Shifts to Production Scale

Tech & Healthcare Earnings

NVIDIA BioNeMo Wins Lilly, Thermo Fisher as AI Drug Discovery Shifts to Production Scale

Salvado•Apr 18, 2026

NVIDIA BioNeMo Platform Adoption Accelerates as Eli Lilly, Thermo Fisher Deploy AI Drug Discovery Infrastructure

Technology Stocks

NVIDIA BioNeMo Platform Adoption Accelerates as Eli Lilly, Thermo Fisher Deploy AI Drug Discovery Infrastructure

Salvado•Apr 10, 2026

NVIDIA's BioNeMo Bets: How Partnerships With Eli Lilly and Thermo Fisher Are Reshaping Drug Discovery Valuations

Technology Stocks

NVIDIA's BioNeMo Bets: How Partnerships With Eli Lilly and Thermo Fisher Are Reshaping Drug Discovery Valuations

ViaNews Editorial Team (Markets)•Feb 18, 2026

NVIDIA's BioNeMo Bets Big on Drug Discovery as Specialized AI Rivals Emerge

NVIDIA's BioNeMo Bets Big on Drug Discovery as Specialized AI Rivals Emerge

ViaNews Editorial Team (Markets)•Feb 18, 2026

Wall Street Ends Flat as Market Uncertainty Continues

Wall Street Ends Flat as Market Uncertainty Continues

ViaNews Editorial Team (Markets)•Jan 18, 2026